Abstract Previously, CD8 + T cells were found to be a sensitive target for suppression by Δ 9 -tetrahydrocannabinol (Δ 9 -THC) in a murine model of influenza infection. To study the effect of Δ 9 -THC on CD8 + cytotoxic T lymphocytes (CTL), an allogeneic model of MHC I mismatch was used to elicit CTL. In addition, to determine the requirement for the cannabinoid receptors 1 (CB 1 ) and 2 (CB 2 ) in Δ 
Introduction
Several cannabinoid compounds including Δ 9 -THC have been implicated in the modulation of immune responses (Howlett et al. 2002; Klein et al. 2003) . Cannabinoid compounds exert their activity, in part, by ligation of two identified targets, CB 1 and CB 2 (Maresz et al. 2007 ). However, studies using antagonists to these receptors, low affinity cannabinoid agonists, and mice lacking CB 1 and/or CB 2 , have demonstrated that not all aspects of immune modulation by cannabinoid compounds can be attributed to CB 1 and/or CB 2 Buchweitz et al. 2008; Springs et al. 2008; De Petrocellis and Di Marzo 2010) . Thus, despite the ability to bind CB 1 and CB 2 , the mechanism and cellular target(s) for Δ 9 -THC within the immune system remain elusive. In particular, recent studies revealed that in T cells, the effect of Δ 9 -THC on immune competence was found to occur independent of CB 1 and CB 2 Rao and Kaminski 2006) , an observation concordant with CB 1 and CB 2 expression, which is much lower on T cells compared to other leukocyte subpopulations (Galiegue et al. 1995) . To further investigate the effects of Δ 9 -THC on T cell responses, an in vivo influenza challenge model was used and showed that the CD8 + T cell population exhibited marked sensitivity to modulation by Δ 9 -THC (Buchweitz et al. 2007 ). These results suggested that CD8 + T cells might be a particularly sensitive T cell subset to cannabinoid-mediated immune modulation and might also represent a useful cellular target to gain novel insights into the molecular mechanisms of cannabinoid action.
The CD8 + surface marker distinguishes a lineage of T cells that are capable of interaction with major histocompatibility complex I (MHC I). To become fully functional, naïve CD8 + T cells must be activated, proliferate, and differentiate into CTL effectors. CTL are important in antiviral and antitumor immune responses. In addition to releasing cytokines pleiotropically involved in immune defense, CTL release cytotoxic granules or interact by cell contact with target cells to induce apoptosis in order to rid tissues of virus-infected or neoplastic cells (Boissonnas et al. 2007; Stinchcombe and Griffiths 2007) . Lysis of target cells and the production of IFNγ are most often used as indicators of CTL function (Slifka et al. 1999; Sun et al. 2003) . To experimentally elicit CTL from naïve CD8 + T cells, several models have been developed, among them is an allogeneic model using P815 (DBA2-derived) tumor cells to activate lymphocytes from a haplotype mismatched donor, such as C57Bl/6 mice. Using this model, CTL are generated in response to a T cell receptor-MHC mismatch and upon subsequent encounter, their effector function can be assayed (Engers et al. 1975) . The objective of this study was to determine the effect of Δ 9 -THC and the involvement of CB 1 and CB 2 on CTL elicitation and function.
Methods

Animals
C57Bl/6 mice were ordered from the National Cancer Institute (NCI) and CB 1 
CB 2
−/− mice were euthanized, the spleens isolated in a sterile environment, and splenocytes enumerated using a Coulter Counter (Beckman Coulter, Brea, CA). P815 cells were irradiated with 3000 rads to prevent proliferation, washed 3 times with RPMI and counted using a hemacytometer. Splenocytes and irradiated P815 cells were combined at 1×10 6 and 1×10 5 cells, respectively, in RPMI 1640 supplemented with 5% bovine calf serum (BCS) in a total volume of 200 μL in a round bottom 96 well plate. The plates were incubated in a humidified incubator with 5% CO 2 at 37°C for the indicated amounts of time.
Drug treatment
At the time of co-culture of splenocytes and irradiated P815, Δ 9 -THC (1, 5, 10 μM), vehicle (VH, 0.1% ethanol) or RPMI (NA) was added. All Δ 9 -THC treatments had the same ethanol content (0.1%) as vehicle control. 51 Cr release assay After elicitation, cells were harvested and washed twice with RPMI 1640 media without serum. P815 cells were washed once and 1×10 6 cells were incubated in the presence of Na 2 51 CrO 4 for 1 h in 10% fetal bovine serum (FBS) supplemented RPMI 1640 media in a volume of less than 50 μL. After incubation P815 cells were washed 3 times using RPMI 1640 media without serum.
51
Cr-labeled P815 cells were adjusted to 1×10 5 cells/mL in 2% FBS RPMI media. Elicited CTL were adjusted in 2% FCS complete RPMI media to ratios ranging from 50 (5×10 IFNγ T cell functional analysis CTL were elicited as described above for generation of CTL. After 5 days, cells were harvested and co-cultured with P815 at a ratio of 10:1 (see above) for 12 h in the presence of brefeldin A to prevent IFNγ release and allow for detection by fluorescently labeled antibody. After coculture, cells were prepared for fluorescent antibody staining (described below).
Proliferation assay
Prior to elicitation, splenocytes were incubated with Cell Trace carboxyfluorescein succinimidyl ester (CFSE) dye (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. CTL were elicited as described above for generation of CTL. Dilution of dye staining is indicative of proliferation and staining profiles from elicited samples were compared to a 24 h SPLC only control, incubated without P815.
T cell activation assays CTL were elicited as described for generation of CTL; however, RPMI supplemented with 2% FCS was used instead of 5%. For direct stimulation, 0.5 μM Io dissolved in 0.01% DMSO in RPMI was used as the Ca 2+ ionophore to induce intracellular Ca 2+ levels, thereby increasing CD69 expression. After 6 h, CD69 surface staining was performed using antibodies specific for CD69 and after 24 h for CD25 (staining described in detail below).
Procedure for immunofluorescent staining for flow cytometry CTL were elicited as described above. Cells were washed in 96 well round bottom plates with HBSS once and incubated with Near IR LIVE/DEAD (Invitrogen) dye to assess viability according to manufacturer's instructions. This dye stains cells that have lost membrane integrity.
Cells were washed twice with FACS buffer (1X HBSS, 1% bovine serum albumin (BSA), 0.1% sodium azide). Subsequently, Fc receptors were blocked using Purified Rat Anti-Mouse CD16/CD32 (BD Pharmingen, San Diego, CA). To stain surface proteins, cells were incubated for 20 min with 0.25-0.5 μg of CD4 (clone RM4-5, Biolegend, San Diego, CA) and CD8 (53-6.7, Biolegend). For the T cell activation experiments, cells were additionally stained with CD69 (H1.2 F3, Biolegend) and CD25 (PC61, Biolegend). Cells were then washed twice and fixed with Cytofix (BD, Franklin Lakes, NJ). After re-stimulation (described above), on the day of flow cytometric analysis, cells were washed once, then permeabilized with Perm/Wash Buffer (BD, Franklin Lakes, NJ) by incubation for 20 min and stained with IFNγ (XMG1.2, Biolegend) for 30 min. All experiments included single stain controls to compensate for fluorescence overlap between detectors. Samples were individually analyzed for percent positive staining as defined by a gate to perform statistical analysis and concatenated by treatment group for graphing using FlowJo v.8.8.6. for Macintosh.
Statistical analysis
Samples were analyzed using ANOVA or non-parametric equivalent Kruskal-Wallis. A p-value of 0.05 or less was deemed statistically significant between experimental and relative control. Regression analysis was performed treating values of each independent variable as a single datum point. All Δ 9 -THC treated samples were compared to vehicle (VH, 0.1% ethanol) control and comparisons between WT and CB 1 −/− CB 2 −/− were performed in naïve (NA) groups.
Stimulation effect was determined between resting (NA-0 h) and NA at the indicated time point of sample collection. Statistical analyses were performed using Graph Pad Prism v4.03.
Results
Kinetics of CTL response
In order to determine the kinetics of the P815-induced CTL response, CTL were elicited for 3, 5, 7, and 9 days after coculture with irradiated P815 cells. Splenocytes from WT and CB 1 −/− CB 2 −/− mice were used as the source of naïve CD8 + T cells. Elicited CTL were assayed for CTL activity by 51 Cr release assay using 51 Cr-labelled P815 target cells. A ratio of 50:1 CTL:P815 cells was used to maximize release, thereby increasing sensitivity on non-peak days.
51
Cr release is a result of CTL-dependent lysis of P815 cells and the peak day of CTL activity occurred at day 5 post elicitation ( Fig. 1) . At the peak day of CTL elicitation, CB 1 −/− CB 2 −/− splenocytes had a statistically significant reduction in CTL activity, when compared to WT (p≤0.01). The same trend was observed for non-peak days, although it was not deemed statistically significant. Subsequent experiments determining CTL effector activity under various conditions were performed at day 5 post elicitation.
Δ 9 -THC suppressed CTL responses during elicitation but not during the effector response To determine the sensitivity of CTL function to Δ 9 -THC treatment in the P815 allogeneic model, Δ 9 -THC and/or vehicle (0.1% ethanol) were added directly to culture during either the elicitation or effector phase of the CTL response. A concentration of 10 μM Δ 9 -THC was used to determine sensitivity of CTL to immune modulation, a concentration that historically impaired T cell immune responses in the absence of direct cytotoxicity (Springs et al. 2008 ). Δ 9 -THC suppressed CTL activity only when added prior to, but not after, the elicitation phase (Fig. 2) . Likewise, repeated addition of Δ 9 -THC during elicitation and effector phases did not further reduce CTL activity below single addition of the drug during the elicitation phase (Fig. 2) .
Concentration-dependent suppression of CTL effector function
Next, we assessed whether CTL responses were suppressed by Δ 9 -THC in a concentration-dependent manner. At E:T ratios ranging from 10:1 to 1:1, Δ 9 -THC suppressed CTL responses in a concentration-dependent manner with statistically significant suppression at concentrations as low as 1 μM (Fig. 3a) . Also, lower E:T ratios resulted in lower CTL Cr labeled P815 cells at a ratio of 10:1 (b) (n=4). Data shown are representative of two repeat experiments. * p≤0.05, ** p≤0.01 indicate differences as compared to VH activity, demonstrating that the elicited cell populations are responsible for the cytolytic activity and that Δ 9 -THC suppressed CTL activity independent of the E:T ratio (Fig. 3a) . Regression analysis was performed on CTL activity results and a statistically significant difference was observed from zero regression values for E:T ratios 10:1 (r 2 = 0.8650, p<0.0001), 5:1 (r 2 =0.7246, p=0.0004), 2.5:1 (r 2 = 0.7461, p=0.0003), and 1:1 (r 2 =0.7692, p=0.0002). Next, we assessed whether the effect by Δ 9 -THC was dependent on the presence of CB 1 and/or CB 2 . Δ 9 -THC suppressed CTL activity in a concentration-dependent manner in CTL elicited from CB 1 −/− CB 2 −/− splenocytes with significantly reduced CTL activity at concentrations of 5 μM or more as in WT (Fig. 3b) . Regression analysis revealed a statistically significant difference from zero regression of E:T ratio of 10:1 in WT (r 2 =0.6893, p=0.0008) and showed the same trend in CB 1 −/− CB 2 −/− albeit not significant (r 2 =0.2905, p=0.0706). Consistent with previous observations, CTL activity of CB 1 −/− CB 2 −/− splenocytes was lower in magnitude compared to WT, although differences in genotypes were not deemed statistically significant.
Although MHC I mismatch is a strong stimulus for driving the expansion of differentiated CD8 + T cell effectors, the overall number of viable T cells within control cultures (NA or VH treatment groups) on day 5 of co-culture with P815 allogenic target cells was modest. This demonstrated that T cell proliferation and clonal expansion in response to MHC I-restricted alloantigens in this assay system induced a relatively small number of T cells from the spleen. To assess the effects of Δ 9 -THC on its ability to impair alloantigeninduced expansion of T cell effectors, the number of viable CD4 + and CD8 + T cells was enumerated on Day 5 of the elicitation phase of the CTL response. Viability was determined using LIVE/DEAD dye (Invitrogen), which permeates dead cells and thus low staining is observed in viable cell populations. The percentage of viable CD4 + ( Fig. 4a and  b) and CD8 + T cells ( Fig. 4c and d) was markedly reduced by Δ Fig. 4a and b) . IFNγ production by CD8 + T cells is often used as a surrogate for CTL activity. After gating for single live cells (Fig. 5a ), CD4 + cells did not produce significant amounts of IFNγ as P815 cells are MHC I-mismatched to C57Bl/6 cells (Fig. 5b) . However, significant IFNγ production was detected by CD8 + cells, which was enhanced in CTL elicited from WT compared to CB 1 −/− CB 2 −/− (Fig. 5c, d and e). In the presence of Δ 9 -THC, enhanced IFNγ production was observed in CD8 + T cells derived from WT and the same trend was observed at higher Δ 9 -THC concentrations in CB 1 −/− CB 2 −/− mice, although not deemed statistically significant (Fig. 5c, d and e). Also, IFNγ production was reduced in samples from CB 1 −/− CB 2 −/− compared to WT mice as previously observed in 51 Cr release assays (Fig. 5c,  d and e). Analysis of CD8 + IFNγ-secreting cells, as a percentage of viable cells, takes into account the reduced viability as a result of Δ 9 -THC addition (see Fig. 4 ). However, while there was an enhancement of IFNγ-secreting cells with Δ 9 -THC treatment, there were also fewer viable cells after Δ 9 -THC treatment, thus overall the percentage of CD8 + cells secreting IFNγ within the total population did not change (Fig. 5f ).
Δ
9 -THC does not affect CD8 + T cell proliferation induced by P815 co-culture Prior to becoming functional CTL, proliferation occurs in T cells to expand the effector pool. Thus, we focused on proliferation as a potential endpoint leading to decreased viability and decreased CTL response. Splenocytes were labeled with CFSE dye to determine proliferation by dye dilution. No statistically significant differences in proliferation were observed between VH and Δ + cells were elicited in samples from WT compared to CB 1 −/− CB 2 −/− spleens ( Fig. 6c and d) .
Increase of CD69 expression on CD8 + cells with Δ
-THC treatment
In an effort to determine events leading to the Δ 9 -THCmediated reduction in cell viability and CTL activity seen at day 5, without any apparent effects on proliferation, we focused on T cell activation. Two markers of cellular activation found on both CD4 + and CD8 + T cells are the expression of CD69 and CD25. Whereas CD69 is thought to be one of the earliest markers of activation and is rapidly upregulated, CD25 expression increases gradually on activated T cells and is observed later than CD69 on activated T cells (Lopez-Cabrera et al. 1995; Brenchley et al. 2002) . We focused on CD69 expression at 6 h and CD25 expression at 12 h after co-culture with irradiated P815 cells. Cells were gated on singlets, by size, and then on CD4 or CD8 (Fig. 7a) . In CD4 + cells, CD69 expression was unaffected by co-culture with P815 cells; however, cells from CB 1 −/− CB 2 −/− mice showed higher basal expression compared to WT mice ( Fig. 7b and c) . In addition, no effect with Δ 9 -THC treatment was observed on CD69 expression on CD4 + cells (Fig. 7b and c) . In contrast, the expression of CD69 on CD8 + was increased by co-culture with P815 cells and CD8 + T cells from CB 1 −/− CB 2 −/− expressed higher levels of CD69 than WT CD8 + T cells ( Fig. 7d and e) . CD69 expression was increased in a concentrationdependent manner by Δ 9 -THC in CD8 + T cells from both WT and CB 1 −/− CB 2 −/− spleens, which was significant at concentrations as low as 5 μM in CB 1 −/− CB 2 −/− -derived cells ( Fig. 7d and e) .
CD25 expression on CD4 + T cells was increased as a result of stimulation with P815 cells and increased levels of CD25 expression were observed in NA unstimulated samples from CB 1 −/− CB 2 −/− compared to WT mice ( Fig. 8a and b ). There was a trend towards a Δ 9 -THCdependent increase in CD25 expression in both WT and CB 1 −/− CB 2 −/− CD4 + cell populations, but this trend was not statistically significant (Fig. 8b) . In CD8 + cells, the expression of CD25 was much lower than in CD4 + cells (Fig. 8a, b, c and d) . Expression of CD25 in CD8 + cells of both genotypes was increased by co-culture with P815 cells (Fig. 8c and d) . In CD8 + cells from CB 1
concentration-dependent decrease with Δ 9 -THC treatment was observed, while in WT Δ 9 -THC had no effect ( Fig. 8c and d ). -THC (1, 5, and 10 μM). After 5 days in culture, CD4 and CD8 surface staining was performed and viability was assessed using LIVE/DEAD staining.
Viability was determined within CD4
+ (a, b) and CD8 + (c, d) cells after singlet and lymphocyte size gating (n=4). Data shown are representative of four repeat experiments. * p≤0.05, ** p≤0.01 indicate differences as compared to VH, ## p≤0.01 as compared to WT Δ 9 -THC-mediated suppression of CTL activity, we focused on intracellular signals leading to CD69 protein expression. Previously, it was determined that independent of CB 1 and CB 2 , Δ 9 -THC partially mediated its effects through the TRPC1 channel, which causes an increase in intracellular Ca 2+ levels (Rao and Kaminski 2006) . Using the calcium ionophore, Io, we tested whether a rise in intracellular Ca 2+ might contribute to the observed increase in CD69 expression. In addition, the effect of Δ 9 -THC on Ioinduced CD69 expression was evaluated. Again, cells were gated as described above (Fig. 7a) . In CD4 + cells, Δ 9 -THC increased expression of CD69 moderately in the absence of an activating stimulus when isolated from CB 1 −/− CB 2 −/− , but not WT mice ( Fig. 9a and c ). Δ 9 -THC increased CD69 expression in CD8 + splenocytes from both WT and CB 1 −/− CB 2 −/− mice in the absence of an activating stimulus ( Fig. 9a and e) . After stimulation with Io, CD69 expression was dramatically increased in CD4 + and CD8 + cells from both genotypes (Fig. 9b, d and f). While CD69 expression was similar between WT and CB 1 Fig. 9b and f) , a marked reduction in CD69 expression was observed in CB 1 −/− CB 2 −/− CD4 + cells, when compared to WT CD4 + cells ( Fig. 9b and d) . Most importantly, Δ 9 -THC synergized with Io to further increase CD69 surface expression in CD4 + and CD8 + cells derived from both genotypes (Fig. 9b, d and f).
Discussion
Collectively, these studies provide evidence that Δ 9 -THCmediated suppression of CD8 + T cell function occurs independent of CB 1 and CB 2 . Moreover, Δ 9 -THC alters early signaling events that involve putative changes in mice (Karsak et al. 2007; Buchweitz et al. 2008) . In a previous study from our laboratory (Buchweitz et al. 2008) , it was demonstrated that CB 1 −/− CB 2 −/− mice, in addition to responding with a greater magnitude to immune stimuli, have altered immune homeostasis compared to WT mice as evidenced by greater numbers of CD4 + T cells and higher levels of TNF-α in the bronchoalveolar lavage fluid in the absence of influenza challenge. In addition, there appeared to be mechanisms in CB 1 −/− CB 2 −/− mice that might compensate for the loss of CB 1 and/or CB 2 , as evidenced by greater levels of the endocannabinoids, 2-arachidonoyl glycerol and anandamide (Karsak et al. 2007) , and increased transcripts of cnr2 using primers specific for the undeleted portion of the gene (Liu et al. 2009 ). Although CB 1 −/− CB 2 −/− mice seem to be particularly vulnerable to proinflammatory insult, there were no drastic differences observed in an adjuvant-free airway hypersensitivity model between CB 1 −/− CB 2 −/− and WT mice (Kaplan et al. 2010) . Reasons for reduced function (Piccirillo and Shevach 2001) . This in vitro model, due to direct stimulation of CTL, lacks a proinflammatory stimulus and does not produce IL-6, which has been implicated in overriding Treg responses, thus Treg responses might be maintained during the in vitro culture (Bettelli et al. 2006 ). As our focus was on the Δ 9 -THC-mediated suppression of CTL responses, we did not further characterize these CD4 + CD25
+ cells for expression of Foxp3 or other cellular markers of the Treg lineage (Fontenot and Rudensky 2005) . Additional studies are required to determine the role of Tregs in CB 1
Addition of Δ 9 -THC during the elicitation and effector response showed that only NA CD8 + cells, but not differentiated CTL, were sensitive to Δ 9 -THC-mediated suppression of CTL function as assessed by 51 Cr release assay, suggesting Δ 9 -THC-mediated immune modulation -THC increases CD69 expression on CD8 + cells in a concentration-dependent manner. Splenocytes from of WT and CB 1 −/− CB 2 −/− mice were incubated with irradiated P815 cells for 6 h to induce CD69 surface expression, in the presence or absence of VH (0.1% ethanol) or Δ 9 -THC (1, 5, and 10 μM). Cells were gated on singlets and lymphocyte populations by size and then on CD4 and CD8 (a). CD4 + (b, c) and CD8 + (d, e) cells positive as defined by the box gate for CD69 in % are shown (n=4). Data shown are representative of three repeat experiments. Difference due to stimulation by P815 is indicated by ++ p≤0.01, due to genotypes by ## p≤0.01, due to Δ 9 -THC by * p≤0.05,** p≤ 0.01 during elicitation. Arguably, the concentrations of Δ 9 -THC at which altered CTL activity was observed in this investigation are higher than detected in the serum of recreational marijuana smokers. However, it is important to emphasize two points. The first is that in addition to Δ 9 -THC, marijuana smoke contains over 60 other structurally-related cannabinoids, a number of which are also well established immune modulators and the majority of which remain to be evaluated for immunomodulatory activity (Ashton 2001; Friedman et al. 2003) . Second, and equally important, the goal of this study was to relate the decrease in viral clearance observed after Δ 9 -THC treatment of animal with influenzainfected airways (Buchweitz et al. 2007 ) and the possibility that this may be due to cannabinoid-mediated suppression in CTL activity. In the case of inhaled marijuana smoke, the cannabinoid concentrations attained in the lung are significantly higher than systemic serum Δ 9 -THC concentrations and may be more closely related to those used in the current study (Azorlosa et al. 1992; Huestis and Cone 2004) . The timeframe of sensitivity to Δ 9 -THC might reflect a high level of T cell plasticity prior to differentiation and reduced plasticity after differentiation (Sundrud et al. 2003) . Other immunomodulatory compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and glucocorticoids exert their greatest effect on early stages of immune cell differentiation and tend to have a lower efficacy if added after the onset of the differentiation program (Piccolella et al. 1985; Tucker et al. 1986) . Specifically, cyclosporin A is very efficacious in suppressing in vitro culture of allogeneic cells only when added prior to elicitation (Hess and Tutschka 1980) . Overall, this suggests a critical window of sensitivity for immunomodulatory compounds, including Δ 9 -THC, for immune suppression, specifically during the transition of NA CD8 + T cells to CTL during elicitation.
Using IFNγ as a surrogate for CTL activity demonstrated that CD8 + cells are the sole producers of IFNγ after allogeneic stimulation, suggesting that only CTL directly contribute to the 51 Cr release from labeled target cells. 
